We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMER icon
1001
Omeros
OMER
$845M
$12K ﹤0.01%
+1,903
New +$13.8K
CNK icon
1002
PUT
Cinemark Holdings
CNK
$4.07B
$8K ﹤0.01%
+500
New +$9.36K
SB icon
1003
CALL
Safe Bulkers
SB
$772M
$8K ﹤0.01%
+2,100
New +$8.56K
VG
1004
CALL
DELISTED
Vonage Holdings Corporation
VG
$8K ﹤0.01%
400
– –
FOXA icon
1005
CALL
Fox Class A
FOXA
$24.8B
$7K ﹤0.01%
+200
New +$7.88K
BFI
1006
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$5K ﹤0.01%
+962
New +$7.36K
CRBP icon
1007
PUT
Corbus Pharmaceuticals
CRBP
$165M
$1K ﹤0.01%
50
– –
SIOX
1008
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1K ﹤0.01%
500
– –
ABNB icon
1009
Airbnb
ABNB
$90.8B
– –
-21,000
Closed -$3.7M
ADI icon
1010
CALL
Analog Devices
ADI
$172B
– –
-26,100
Closed -$4.37M
ADI icon
1011
Analog Devices
ADI
$172B
– –
-6,800
Closed -$1.14M
ADI icon
1012
PUT
Analog Devices
ADI
$172B
– –
-55,200
Closed -$9.24M
AGO icon
1013
Assured Guaranty
AGO
$3.73B
– –
-6,000
Closed -$281K
AI icon
1014
C3.ai
AI
$1.38B
– –
-2,000
Closed -$81K
ALDX icon
1015
CALL
Aldeyra Therapeutics
ALDX
$97.1M
– –
-53,900
Closed -$473K
ALDX icon
1016
Aldeyra Therapeutics
ALDX
$97.1M
– –
-7,000
Closed -$61K
ALDX icon
1017
PUT
Aldeyra Therapeutics
ALDX
$97.1M
– –
-1,300
Closed -$11K
ALEC icon
1018
CALL
Alector
ALEC
$169M
– –
-10,000
Closed -$228K
ALK icon
1019
Alaska Air
ALK
$5.11B
– –
-7,000
Closed -$379K
ALT icon
1020
CALL
Altimmune
ALT
$568M
– –
-78,400
Closed -$887K
AMT icon
1021
American Tower
AMT
$83.5B
– –
-4,500
Closed -$1.23M
AON icon
1022
Aon
AON
$80.6B
– –
-6,300
Closed -$1.8M
AON icon
1023
PUT
Aon
AON
$80.6B
– –
-10,000
Closed -$2.86M
APD icon
1024
PUT
Air Products & Chemicals
APD
$65.5B
– –
-3,000
Closed -$768K
APLS
1025
CALL
DELISTED
Apellis Pharmaceuticals
APLS
– –
-265,700
Closed -$8.76M
39 40
41
42 43

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.